A recent Interesting Engineering article contained good news in the fight against the HIV epidemic. Last Monday, the FDA announced its approval of the first injectable medication for pre-exposure prevention (aka PrEP) against HIV. The drug is called Apretude, and it was developed by ViiV Healthcare, which is majority-owned by GlaxoSmithKline. It is comparable to other HIV prevention pills such as Truvada and Descovy, which reduce HIV transmission risk by 99% when taken daily.
FDA Approves First HIV Prevention Shot
The drug is intended to reduce the risk of HIV transmission via intercourse, and replace ingestible alternatives.
Dec 28, 2021
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
